Drug device configured for wireless communication
First Claim
Patent Images
1. An ingestible drug delivery device, formed by a device manufacturer, and configured for wireless communication, said drug delivery device comprising:
- a capsule body comprising;
a sensor for sensing at least one biologic condition within a patient;
a bioactive substance module comprising a container for holding a volume and/or quantity of bioactive substance therein and a microactuator for dispensing said bioactive substance from said container to a location outside of said capsule body;
an electronics module, coupled to said sensor and said bioactive substance module, said electronics module comprising a processor, a transponder and a memory, said memory configured for storing data related to a unique device ID and to a patient identification and configured for storing respective flags set by the device manufacturer and a pharmacist;
a power source coupled to said sensor, said bioactive substance module and said electronics module; and
wherein said processor activates said microactuator to dispense said bioactive substance only if said processor verifies the following conditions;
(a) a first flag is set by the device manufacturer;
(b) a second flag is set by the pharmacist; and
(c) a match exists between said patient identification stored in said memory and a patient identification transmitted from an external patient interface device that communicates with said ingested drug device; and
wherein said processor does not activate said microactuator to dispense said bioactive substance if any one of said conditions (a) (c) is not verified.
2 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to an ingestible drug delivery device configured for wireless communication with other ingestible drug delivery devices.
-
Citations
21 Claims
-
1. An ingestible drug delivery device, formed by a device manufacturer, and configured for wireless communication, said drug delivery device comprising:
-
a capsule body comprising; a sensor for sensing at least one biologic condition within a patient; a bioactive substance module comprising a container for holding a volume and/or quantity of bioactive substance therein and a microactuator for dispensing said bioactive substance from said container to a location outside of said capsule body; an electronics module, coupled to said sensor and said bioactive substance module, said electronics module comprising a processor, a transponder and a memory, said memory configured for storing data related to a unique device ID and to a patient identification and configured for storing respective flags set by the device manufacturer and a pharmacist; a power source coupled to said sensor, said bioactive substance module and said electronics module; and wherein said processor activates said microactuator to dispense said bioactive substance only if said processor verifies the following conditions; (a) a first flag is set by the device manufacturer; (b) a second flag is set by the pharmacist; and (c) a match exists between said patient identification stored in said memory and a patient identification transmitted from an external patient interface device that communicates with said ingested drug device; and wherein said processor does not activate said microactuator to dispense said bioactive substance if any one of said conditions (a) (c) is not verified. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
-
Specification